Heavy metal toxicity in humans and its preventive and control measures

Current Nutrition and Food Science

Volumn 7, Issue 4, 2011, Pages 221-231

  Gupta, Umesh C ^a   Gupta, Subhas C ^b  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Chelation; Environment; Human diseases; Mining; Preventive measures; Trace elements

Indexed keywords

ACTIVATED CARBON; ALPHA TOCOPHEROL; ALUMINUM; ALUMINUM PHOSPHATE; ARSENIC; CADMIUM; COPPER; DIMERCAPROL; DRINKING WATER; EDETATE CALCIUM DISODIUM; EDETIC ACID; HEAVY METAL; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; LEAD; MERCURY; PENICILLAMINE; REACTIVE OXYGEN METABOLITE; SUCCIMER; UNITHIOL; ZINC;

ABDOMINAL PAIN; ACUTE TOXICITY; ALUMINUM OVERLOAD; ALZHEIMER DISEASE; AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; ANEMIA; APOPTOSIS; ARSENIC POISONING; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BIRTH WEIGHT; BRAIN DISEASE; CADMIUM TOXICITY; CHELATION THERAPY; CHEST TIGHTNESS; CHOLESTASIS; CHRONIC FATIGUE SYNDROME; CHRONIC TOXICITY; COGNITIVE DEFECT; COMA; CONCENTRATION LOSS; CONVULSION; COPPER TOXICITY; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISTAL PARESTHESIA; DIZZINESS; DNA REPAIR; EXCITOTOXICITY; FASCIITIS; GENOTOXICITY; HEADACHE; HEAVY METAL POISONING; HEMOLYSIS; HUMAN; HYPERGLYCEMIA; IMMUNOGLOBULIN PRODUCTION; INSOMNIA; KERATOSIS; KIDNEY DYSFUNCTION; LEAD POISONING; LIVER NECROSIS; MACROPHAGIC MYOFASCIITIS; MALAISE; MERCURIALISM; NERVE DEGENERATION; NEUROTOXICITY; OXIDATIVE STRESS; PARENTERAL NUTRITION; PARKINSON DISEASE; PREMATURITY; PRIORITY JOURNAL; PROSTATE CANCER; SALIVARY GLAND DISEASE; STOMACH LAVAGE; STUPOR; URINE LEVEL; VOMITING; WATER CONTAMINATION; ZINC TOXICITY;

EID: 84863351912     PISSN: 15734013     EISSN: 22123881     Source Type: Journal    
DOI: 10.2174/157340111804586510     Document Type: Article

References (150)

1. Coen N, Mothersill C, Kadhim M. Heavy metals of relevance to human health induce genomic instability. J Pathol 2001; 195: 293-9.
2. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161-208.
3. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003; 68: 167-82.
4. Stewart-Pinkham SM. The relative role of cadmium and lead in disease. Int J Biosocial Med Res 1989; 11: 121-33.
5. van Campen DR. Trace elements in human nutrition. In: Mortvedt et al. (Eds.) Micronutrients in Agriculture. SSSA Book Series 4, 2nd ed., SSSA, Inc. Madison, WI 1991; pp. 663-701.
6. Eife R, Weiss M, Barros V, et al. Chronic poisoning by copper in tap water: I. Copper intoxicants with predominantly gastrointestinal symptoms. Eur J Med Res 1999; 4: 219-23.
7. Becaria A, Campbell A, Bondy SC. Aluminum as a toxicant. Toxicol Ind Health 2002; 18: 309-20.
8. Anonymous http://www.natmedtalk.com/vitamins/19838-aluminum-magnesium-link.html
9. Price KA, Crouch J, White AR. Therapeutic treatment of Alzheimer's disease using metal complexing agents. Recent Pat CNS Drug Discov 2007; 2: 180-7.
10. Frisardi V, Solfrizzi V, Capurso C, et al. Aluminum in the diet and Alzheimer's disease: From current epidemiology to possible disease-modifying treatment. J Alzheimer's Dis 2010; 20: 17-30.
11. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 2009; 169: 489-96.
12. Miu AC, Benga O. Aluminum and Alzheimer's disease: a new look. J Alzheimer's Dis 2006; 10: 179-201.
13. Nayak P. Aluminum: impacts and disease. Environ Res 2002; 89: 101-15.
14. Soni MG, White SM, Flamm WG, Burdock GA. Safety evaluation of dietary aluminum. Regul Toxicol Pharmacol 2001; 33: 66-79.
15. Gura KM. Aluminum contamination in products used in parenteral nutrition: Has anything changed? Nutrition 2010; 26: 585-94.
16. Exley C, Swarbrick L, Gherardi RK, Authier FJ. A role for the body burden of aluminum in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 2009; 72: 135-9.
17. Meyer-Baron M, Schaper M, Knapp G, van Thriel C. Occupational aluminum exposure: evidence in support of its neurobehavioral impact. Neurotoxicology 2007; 28: 1068-78.
18. Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimer's Dis 2005; 8: 171-82 (Discussion 209-15).
19. Han S, Sakinci U, Kose SK, Yazkan R. The relationship between aluminum and spontaneous pneumothorax; treatment, prognosis, follow-up? Interact Cardiovasc Thorac Surg 2004; 3: 79-82.
20. Sorgdrager B, De Looff AJA, De Monchy JGR, Pal TM, Dubois AE, Rijcken B. Occurrence of occupational asthma in aluminum potroom workers in relation to preventive measures. Int Arch Occup Environ Health 1998; 71: 53-9.
21. Hderez G, Kraut JA, Andress DA. Use of calcium carbonate as a phosphate binder in dialysis patients. Mineral Electrolyte Metabolism 1986; 12: 314-9.
22. Crouch PJ, White AR, Bush AI. The modulation of metal bioavailability as a therapeutic strategy for the treatment of Alzheimer's disease. FEBS J 2007; 274: 3775-83.
23. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, de La Guéronnière V, Grandjean H, Vellas B. Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study. Am J Clin Nutr 2005; 81: 897-902.
24. Yokel RA. The toxicology of aluminum in the brain: a review. Neurotoxicology 2000; 21: 813-28.
25. Anonymous. Cadmium-no cause for complacency. New Scientist, August 19, 1982; 195 (1319): pp. 484.
26. Glick JL. Dementias: the role of magnesium deficiency and a hypothesis concerning the pathogenesis of Alzheimer's disease. Med Hypotheses 1990; 31: 211-25.
27. Dalal B, Nayak K, Gangopadhyay PK, Mukherjee AK. Identification of indicators of arsenic induced hepatic damage in human. Internet J Toxicol 2009; 7: 1.
28. Banerjee M, Banerjee N, Ghosh, P, et al. Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage. Toxicol Appl Pharmacol 2010; 249: 47-54.
29. Fatmi Z, Azam I, Ahmed F, et al. Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source? Environ Res 2009; 109: 575-81.
30. Chen JG, Chen YG, Zhou YS, et al. A follow-up study of mortality among the arseniasis patients exposed to indoor combustion of high arsenic coal in Southwest Guizhou Autonomous Prefecture, China. Int Arch Occup Environ Health 2007; 81: 9-17.
31. Majumdar KK, Mazumder DNG, Ghose N, Ghose A, Lahiri S. Systemic manifestations in chronic arsenic toxicity in absence of skin lesions in West Bengal. Indian J Med Res 2009; 129: 75-82.
32. Andrew AS, Mason RA, Memoli V, Duell EJ. Arsenic activates EGFR pathway signaling in the lung. Toxicol Sci 2009; 109: 350-7.
33. Halatek T, Sinczuk-Walczuk H, Rabieh S, Wasowicz W. Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol Appl Pharmacol 2009; 239: 193-9.
34. Mazumder DNG. Chronic arsenic toxicity & human health. Indian J Med Res 2008; 128: 436-47.
35. Xu Y, Wang Y, Zheng Q, et al. Clinical manifestations and arsenic methylation after a rare subacute arsenic poisoning accident. Toxicol Sci 2008; 103: 278-84.
36. Pandey PK, Yadav S, Pandey M. Human arsenic poisoning issues in central-east Indian locations: Biomarkers and biochemical monitoring. Int J Environ Res Public Health 2007; 4: 15-22.
37. Yarris JP, Caravati EM, Horowitz ZB, Stromness JR, Crouch BI, Mckeown NJ. Acute arsenic trioxide ant bait ingestion by toddlers. Clin Toxicol 2008; 46: 785-9.
38. Maharjan M, Watanabe C, Ahmad SA, Umezaki M, Ohtsuka R. Mutual interaction between nutritional status and chronic arsenic toxicity due to groundwater contamination in an area of Terai, lowland Nepal. J Epidemiol Community Health 2007; 61: 389-94.
39. Mukherjee SC, Saha KC, Pati S, et al. Murshidabad-One of the nine groundwater arsenic-affected districts of West Bengal, India. Part II: Dermatological, neurological, and obstetric findings. Clinic Toxicol 2005; 43: 835-48.
40. Parga JR, Cocke DL, Valenzuela JL, et al. Arsenic removal via electrocoagulation from heavy metal contaminated groundwater in La Comarca Lagunera Mexico. J Hazard Mater 2005; 124: 247-54.
41. Ahamed S, Sengupta MK, Mukherjee SC, et al. An eight-year study report on arsenic contamination in groundwater and health effects in Eruani Village, Bangladesh and an approach for its mitigation. J Health Popul Nutr 2006; 24: 129-41.
42. Hassan MM, Atkins PJ, Dunn CE. Social implications of arsenic poisoning in Bangladesh. Soc Sci Med 2005; 61: 2201-11.
43. Bernard, A. Cadmium & its adverse effects on human health. Indian J Med Res 2008; 128: 557-64.
44. Pan J, Plant JA, Voulvoulis N, Oats CJ, Ihlenfeld C. Cadmium levels in Europe: implications for human health. Environ Geochem Health 2010; 32: 1-12.
45. Olsson IM, Eriksson J, Oborn I, Skerfving S, Oskarsson A. Cadmium in food production systems: a health risk. Cadmium in food production systems: a health risk for sensitive population groups. Ambio 2005; 34: 344-51.
46. Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009; 238: 201-8.
47. Satarug S, Haswell-Elkins MR, Moore MR. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Brit J Nutr 2000; 84: 791-802.
48. Page AL, Chang AC. Trace elements of environmental concern in terrestrial ecosystems: an overview: 15th World Congress of Soil Science, Acapulco, Mexico, July 10-16, 1994 Transaction, Vol. 3a Comm. II Symposia 1994; pp. 568-71.
49. Thompson J, Bannigan J. Cadmium: toxic effects on the reproductive system and the embryo. Reprod Toxicol 2008; 25: 304-15.
50. Takizawa Y. Cadmium-binding proteins in human organs Toxicol Lett 1982; 11: 269.
51. Van Wijngaarden E, Singer EA, Palapattu GS. Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 national health and nutrition examination survey. The Prostate 2008; 68: 122-8.
52. Kelley R. Element deficiency and toxicity, In: Berkow R, Ed. The Merck Manual of Diagnosis and Therapy: Publ. Merck Res. Lab., Div. of Merck & Co. Inc. Rahway, NJ. 1992; pp. 975-81; 2685-97.
53. Nordberg G. Excursions of intake above ADI: case study on cadmium. Regulatory toxicology and pharmacology 1999; 30: S57-S62.
54. Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Aappl Pharmacol 2009; 238: 289-93.
55. Nordberg GF. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 2009; 238: 192-200.
56. Tsuritani I, Honda R. The effects on bone of environmental cadmium exposure-summary of recent epidemiological studies. Clin Calcium 2004; 14: 45-50.
57. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med 2004; 229: 383-92.
58. Houston MC. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Therapies Health Med 2007; 13: S128-S133.
59. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 2004; 17: 519-23.
60. Andersen O, Nielsen JB, Nordberg GF. Nutritional interactions in intestinal cadmium uptake--possibilities for risk reduction. Biometals 2004; 17: 543-7.
61. Brzóska MM, Moniuszko-Jakoniuk J. Interactions between cadmium and zinc in the organism. Food Chem Toxicol 2001; 9: 967-80.
62. Kelley C. Cadmium therapeutic agents. Curr Pharm Design 1999; 5: 229-40.
63. Roels HA, Hoet P, Lison D. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Renal Failure 1999; 21: 251-62.
64. Brzóska MM, Moniuszko-Jakoniuk J. The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch Toxicol 1997; 72: 63-73.
65. Stern, BR. Essentiality and toxicity in copper health risk assessment: overview, update and regulatory considerations. J Toxicol Environ Health Part A 2010; 3: 114-27.
66. Brewer GJ. Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 2010; 23: 319-26.
67. Brewer GJ. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2005; 19: 185-92.
68. Bosshard E, Zimmerli B. Utensils of copper and copper alloys, a health problem. Mitt Geb Lebensmittelunters Hyg 1994; 85: 287-311.
69. Brewer GJ. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease. J Am Coll Nutr 2009; 28: 238-42.
70. Randolph LM, Rotter JI. Hereditary disorder of the gut and liver. In: Kelley W N. Ed. Textbook of Internal Medicine. J.B. Lippincot Company, Philadelphia, PA. 1989; pp. 630-49.
71. Glenn MG, Weymuller EA Jr. Diseases of the upper airway. In: Kelley W N, Ed. Textbook of Internal Medicine. JB Lippincot Company, Philadelphia, PA. 1989; pp.1865-873.
72. Brewer GJ. The risks of free copper in the body and the development of useful anticopper drugs. Curr Opinion Clin Nutr Metab Care 2008; 11: 727-32.
73. Brewer GJ. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Exp Biol Med 2007; 232: 323-35.
74. Donoso A, Cruces P, Camacho, J. Acute respiratory distress syndrome resulting from inhalation of powdered copper. Clin Toxicol 2007; 45:714-16.
75. Gunay N, Yildirim C, Karcioglu O, et al. A series of patients in the emergency department diagnosed with copper poisoning: recognition equals treatment. Tohoku J Exp Med 2006; 209: 243-48.
76. Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003; 189: 147-63.
77. Gidlow DA. Lead toxicity. Occup Med 2004; 54: 76-81.
78. Dounias G, Rachiotis G, Hadjichristodoulou C. Acute lead intoxication in a female battery worker: Diagnosis and management. J Occup Med Toxicol 2010; 5: 19.
79. De Capitani EM. Diagnosis and treatment of lead poisoning in children and adults. Diagnóstico e tratamento da intoxicação por chumbo em crianças e adultos. Medicina Brazil 2009; 42: 309-19.
80. Rosin A. The long-term consequences of exposure to lead. Isr Med Assoc J 2009; 11: 689-94.
81. Mudipalli A. Lead hepatotoxicity & potential health effects. Indian J Med Res 2007; 126: 518-27.
82. Nemsadze K, Sanikidze T, Ratiani L, Gabunia L, Sharashenidze T. Mechanisms of lead-induced poisoning. Georgian Med News (Jul-Aug) 2009; 92-6.
83. Lanphear BP, Dietrich KN, Berger O. Prevention of lead toxicity in US children. Ambul Pediatr 2003; 3: 27-36.
84. Langston JW, Irwin I. Lead, mercury, and manganese. In: Kelley WN. Ed. Textbook of Internal Medicine. J.B. Lippincot Company, Philadelphia, PA 1989; pp. 2447-51.
85. Stoleski S, Karadşinska-Bislimovska J, Stikova E, Risteska-Kuc S, Mijakoski D, Minov J. Adverse effects in workers exposed to inorganic lead. Arh Hig Rada Toksikol 2008; 59: 19-29.
86. Shiri R, Ansari M, Ranta M, Falah-Hassani K. Lead poisoning and recurrent abdominal pain. Ind Health 2007; 45: 494-6.
87. Kokayi K, Altman CH, Callely RW, Harrison A. Findings of and Treatment for High Levels of Mercury and Lead Toxicity in Ground Zero Rescue and Recovery Workers and Lower Manhattan Residents. Explore (NY) 2006; 2: 400-7.
88. Milanov I, Kolev P. Clinical and electromyographic examinations of patients with tremor after chronic occupational lead exposure. Occup Med 2001; 51: 157-62.
89. White LD, Cory-Slechta DA, Gilbert ME, et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 2007; 225: 1-27.
90. Lutz PM, Wilson TJ, Ireland J, et al. Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead. Toxicology 1999; 134: 63-78.
91. Flora SJS, Flora G, Saxena G, Mishra M. Arsenic and lead induced free radical generation and their reversibility following chelation. Cell Mol Biol 2007; 53: 26-47.
92. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit 2006; 12: RA57-65.
93. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002; 80: 33-44.
94. Khan DA, Qayyum S, Saleem S, Ansari WM, Khan FA. Lead exposure and its adverse health effects among occupational worker's children. Toxicol Ind Health 2010; 26: 497-504.
95. Wills BK, Christensen J, Mazzoncini J, Miller M. Severe neurotoxicity following ingestion of tetraethyl lead. J Med Toxicol 2010; 6: 31-4.
96. Shobha N, Taly A, Sinha S, Venkatesh T. Radial neuropathy due to occupational lead exposure: Phenotypic and electrophysiological characteristics of five patients. Ann Indian Acad Neurol 2009; 12: 111-5.
97. Kosnett MJ, Wedeen RP, Rothenberg SJ, et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007; 115: 463-71.
98. Bradberry S, Sheehan T, Vale A. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. Q J M 2009; 102: 721-32.
99. Bradberry S, Vale AA. Comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning Sodium calcium edetate and DMSA in lead poisoning. Clin Toxicol 2009; 47: 841-58.
100. Restek-Samarzija N, Blanusa M, Pizent A, et al. Meso-2, 3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers. Arhiv za Higijenu Rada i Toksikologiju 1998; 49: 137-45.
101. Hurtado CM, Gutiérrez M, Echeverry J. Clinical manifestations of lead levels in children exposed to automobile battery recycling processes in Soacha and Bogotá, D.C. Aspectos clínicos y niveles de plomo en niños expuestos de manera paraocupacional en el proceso de reciclaje de baterías de automóviles en las localidades de Soacha y Bogotá, D. C. Biomedica 2008; 28: 116-25.
102. Manay N, Cousillas AZ, Alvarez C, Heller T. Lead contamination in Uruguay: the "La Teja" neighborhood case. Rev Environ Contam Toxicol 2008; 195: 93-115.
103. Meyer PA, Brown MJ, Falk H. Global approach to reducing lead exposure and poisoning. Mutat Res 2008; 659: 166-75.
104. Tutdibi E, Gomes T, Lindner U, Gortner L. Lead poisoning in children. Definition, exposure, symptoms, diagnosis and management. Internist Prax 2008; 48: 685-91.
105. Patrick L. Lead toxicity, a review of the literature. Part I: Exposure, evaluation, and treatment. Alter Med Rev 2006; 11: 2-22.
106. Gracia RC, Snodgrass WR. Lead toxicity and chelation therapy. Am J Health-System Phar 2007; 64: 45-53.
107. Chuang HY, Chao KY, Tsai SY. Reversible neurobehavioral performance with reductions in blood lead levels-a prospective study on lead workers. Neurotoxicol Teratol 2005; 27: 497-504.
108. Markowitz ME. Managing childhood lead poisoning. Salud Publica de Mexico. 2003; 45 (Suppl 2): S225-S231.
109. Dawson EB, Evans DR, Harris WA, Teter MC, McGanity WJ. The effect of ascorbic acid supplementation on the blood lead levels of smokers. J Am Coll Nutr 1999; 18: 166-70.
110. Magos L, Clarkson TW. Overview of the clinical toxicity of mercury. Ann Clinical Biochem J 2006; 43: 257-68.
111. Honda S, Hylander L, Sakamoto M. Recent advances in evaluation of health effects on mercury with special reference to methylmercury
112. Guzzi G, La Porta CA. Molecular mechanisms triggered by mercury. Toxicology 2008; 244: 1-12.
113. Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110 (S1): 11-23.
114. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect 2002; 110 (Suppl 4): 597-9.
115. Ritter K. Study warns of mercury pollution in Arctic. The Guardian, Charlottetown, PE, Canada, B8, May 06, 2011.
116. Crespo-López ME, Macêdo GL, Pereira SID, et al. Mercury and human genotoxicity: Critical considerations and possible molecular mechanisms. Pharmacol Res 2009; 60: 212-20.
117. Holmes P, James KA, Levy LS. Is low-level environmental mercury exposure of concern to human health? Sci Total Environ 2009; 408: 171-82.
118. Austin D. An epidemiological analysis of the 'autism as mercury poisoning' hypothesis. Int J Risk Safety Med 2008; 20: 135-42.
119. Geier DA, King PG, Sykes LK, Geier MR. A comprehensive review of mercury provoked autism. Indian J Med Res 2008; 128: 383-411.
120. Balshaw S, Edwards J, Daughtry B, Ross K. Mercury in seafood: mechanisms of accumulation and consequences for consumer health. Rev Environ Health 2007; 22: 91-113.
121. Ekino S, Susa M, Ninomiya T, Imamura K, Kitamura T. Minamata disease revisited: an update on the acute and chronic manifestations of methyl mercury poisoning. J Neurol Sci 2007; 262: 131-44.
122. Crinnion WJ. Environmental medicine, part three: Long-term effects of chronic low-dose mercury exposure. Altern Med Rev 2000; 5: 209-23.
123. Kazantzis G. Mercury exposure and early effects: An overview. Med Lav 2002; 93: 139-47.
124. Mutter J, Naumann J, Guethlin C. Comments on the article "The toxicology of mercury and its chemical compounds" by Clarkson and Magos (2006). Crit Rev Toxicol 2007; 37: 537-49.
125. Risher JF, Amler SN. Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. Neurotoxicology 2005; 26: 691-9.
126. Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, et al. DMPS (2, 3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther 1998; 287: 8-12.
127. Bitanihirwe BKY, Cunningham MG. Zinc: the brain's dark horse. Synapse 2009; 63: 1029-49.
128. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006; 20: 3-18.
129. Plum LM, Rink L, Haase H. The Essential Toxin: Impact of Zinc on Human Health. Int J Environ Res Public Health 2010; 7: 1342-65.
130. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol 2006; 80: 1-9.
131. Sugiura T, Goto K, Ito K, Ueta A, Fujimoto S, Togari H. Chronic zinc toxicity in an infant who received zinc therapy for atopic dermatitis. Acta Paediatr (Int J Paediat) 2005; 94: 1333-5.
132. Solomons NW. Competitive mineral-mineral interaction in the intestine. In: Inglett GE. Ed. Nutritional bioavailability of zinc. Am Chem Soc, Washington, D.C. 1983; pp. 147-271.
133. Hooper P, Visconti L, Garry PJ, Johnson JE. Zinc lowers highdensity lipoprotein cholesterol levels. J Am Med Assoc 1980; 244: 1960-1.
134. Cai L, Li XK, Song Y, Cherian MG. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem 2005; 12: 2753-63.
135. Tubek S. Zinc supplementation or regulation of its homeostasis: Advantages and threats. Biol Trace Elem Res 2007; 119: 1-9.
136. Frederickson CJ, Maret W, Cuajungco MP. Zinc and excitotoxic brain injury: a new model. Neuroscientist 2004; 10: 18-25.
137. Barceloux DG. Zinc. J Toxicol-Clin Toxicol 1999; 37: 279-92.
138. Shraim A, Cui X, Li S, et al. Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coalburning in Guizhou, PR China. Toxicol Lett 2003; 137: 35-48.
139. Basu A, Mahata J, Roy AK, et al. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2002; 516: 29-40.
140. Mitra AK, Bose BK, Kabir H, Das BK, Hussain M. Arsenic-related health problems among hospital patients in Southern Bangladesh. J Health Popul Nutr 2002; 20: 198-204.
141. Araya M, McGoldrick MC, Klevay LM, et al. Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water. Regul Toxicol Pharm 2001; 34: 137-45.
142. Araya M, Olivares M, Pizarro F, Llanos A, Figueroa G, Uauy R. Community-based randomized double-blind study of gastrointestinal effects and copper exposure in drinking water. Environ Health Perspect 2004; 112:1068-73.
143. Barceloux DG. Copper. J Toxicol-Clin Toxicol 1999; 37: 217-30.
144. Case Studies in Environment Medicine (CSEM): Lead Toxicity. Agency for Toxic Substances and Disease Registry http://www.atsdr.gov/csem/lead/pb standards2.html
145. Dona A, Dourakis S, Papadimitropoulos B, Maravelias C, Koutselinis A. Flour contamination as a source of lead intoxication. J Toxicol Clin Toxicol 1999; 37: 109-12.
146. Autenrieth T, Schmidt T, Habscheid W. Lead poisoning caused by drinking from a Greek ceramic cup. Bleivergiftung durch griechische Keramiktasse 1998; 123: 353-8.
147. Passos CJS, Mergler D. Human mercury exposure and adverse health effects in the Amazon: a review. Cadernos de Saude Publica 2008; 24 (Suppl 4): s503-s520.
148. Herring WB, Leavell BS, Paixo LM, Yoe JH. Trace metals in human plasma and red blood cells: a study of magnesium, chromium, nickel, copper and zinc. I. Observations of normal subjects. Am J Clin Nutr 1960; 8: 846-54.
149. Lewis MR, Kokan L. Zinc gluconate: acute ingestion. J Toxicol Clin Toxicol 1998; 36: 99-101.
150. Garcia-Leston J, Mendez J, Pasaro E, Laffon B. Genotoxic effects of lead: an updated review. Environ Int 2010; 36: 623-36.